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SAKUMA et Al. resulted in continuous expression of Cas9 until at least 72 hr post-transfection (Kim, Kim, Cho, Kim, & Kim, 2014) . Therefore, Cas9 RNPs are apparently more suitable for the establishment of homogeneous clones than plasmid vectors.
After the initial examination by Kim and colleagues, successful examples of Cas9 RNP-mediated cell engineering via electroporation were reported by many groups (Lin, Staahl, Alla, & Doudna, 2014; Richardson, Ray, DeWitt, Curie, & Corn, 2016; Schumann et al., 2015) . Moreover, other strategies for RNP delivery mediated by cell-penetrating peptides (Ramakrishna et al., 2014) and cationic lipids (Jacobi et al., 2017; Liang et al., 2015; Zuris et al., 2015) were applied for cultured cell engineering. Of these, cationic lipid-mediated transfection (i.e., lipofection) is particularly useful, because it requires neither equipment nor engineering of Cas9 protein. Recently, lipofection of Cas9 RNP has become a widely applicable technique for cell engineering, according to the latest report (Yu et al., 2017) . The lipofection reagent, named Lipofectamine CRISPRMAX Cas9 Transfection Reagent (Thermo Fisher Scientific, Waltham, MA, USA), was optimized to introduce Cas9 RNPs, and high-efficiency targeted mutagenesis was achieved in diverse cell lines.
In the initial study by Kim and colleagues and various subsequent studies, in vitro-transcribed gRNAs using the T7 RNA polymerase system were typically used. Meanwhile, Aida and colleagues reported a cloning-free CRISPR-Cas9 system, comprising Cas9 protein and chemically synthesized dual RNAs, to maximize the convenience of Cas9 RNPs (Aida et al., 2015) . Natural type-II CRISPR-Cas systems harness CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA) as the gRNA (Wiedenheft, Sternberg, & Doudna, 2012) . In genome editing applications, a single chimeric gRNA is commonly used, but its length (~100 nt) is a little too large for chemical synthesis. Therefore, Aida and colleagues separated the chimeric gRNA into crRNA and tracrRNA, and proved the functionality of Cas9 RNPs containing the dual RNAs in genome editing applications. Through the development of this cloning-free system, we can obtain a functional CRISPR-Cas9 reagent simply by commercial sources.
In this study, we carried out lipofection of cloning-free Cas9 RNPs in HCT116 cells, followed by single-cell cloning at 24, 48, 72 hr, and 1 week post-transfection, ~2 weeks of incubation and genotyping for analysis of heterogeneity to investigate the optimal timing for single-cell cloning after the introduction of CRISPR-Cas9.
| RESULTS
| Experimental design and activity validation of crRNAs
To rigorously examine the degree of heterogeneity in clonal cells, we first designed the experimental procedures carefully.
Regarding the cell type and target site, we selected HCT116 cells and the HPRT1 locus, respectively. Each HCT116 cell has only one allele of the HPRT1 gene, because the HPRT1 gene is located on the X chromosome and HCT116 cells are derived from a male with XY sex chromosomes. Therefore, the occurrence of heterogeneity can be confirmed if multiple alleles are observed in the clonal cells.
We designed five crRNAs targeting the third exon of the HPRT1 gene as candidates ( Figure 1a ) and identified their potential off-target sites using a cosmid software (Cradick, Qiu, Lee, Fine, & Bao, 2014) . The top candidate site of each crRNA was chosen in accordance with the scores calculated by cosmid, except that two sites were chosen for the crRNA #2 (OT2-1 and OT2-2), because their scores were the same (Figure 1b) . Subsequently, the on-and off-target activities were evaluated in HCT116 cells by genomic cleavage detection assays (Figure 1c) . Four of the crRNAs exhibited sufficient on-target activities with mutation efficiencies approximately 30%-40%, while the activity of crRNA #3 was relatively low (9.0%). Therefore, we obtained four candidate crRNAs (#1, #2, #4 and #5) for the heterogeneity assessment. Regarding the off-target activities, mutations were detected at two of six candidate sites (Figure 1c) .
Increasing the chance of cleavage events, resulting in various types of mutations, is considered important for the appearance of heterogeneity. Therefore, we conceived the idea of using a multiple targeting strategy mediated by simultaneous introduction of two or three crRNAs. Multiple targeting using several gRNAs was previously used for efficient inactivation of target genes (Sunagawa et al., 2016) . We selected the following two combinations: crRNA #1 and #4 designated the RNP_1 + 4 group, and crRNA #2, #4 and #5 designated the RNP_2 + 4 + 5 group (Figure 2a ). In the RNP_1 + 4 group, simultaneous double cleavages should typically result in 66-bp deletion. In the RNP_2 + 4 + 5 group, 40-, 49-or 89-bp deletion should occur by double or triple cleavages.
Another important configuration of a heterogeneity analysis is a reliable system for transfection and single-cell cloning. Regarding transfection, we initially validated the mutation efficiency by Cas9 RNP introduction via lipofection and electroporation in HCT116 cells. Consistent with the previous report (Yu et al., 2017) , the lipofection reagent, CRISPRMAX, could introduce mutations efficiently; however, the mutation efficiency of RNP electroporation was much lower than that of lipofection in our hands (data not shown). Therefore, we have selected CRISPRMAX-mediated lipofection as the transfection method. Regarding single-cell cloning, manual cloning methods such as limiting dilution and colony isolation are often used for genome editing applications in cultured cells (Nakade et al., 2014; Sakuma et al., 2015; Takayama et al., 2017) . However, single-cell cloning cannot be guaranteed with these methods. Furthermore, these methods are too laborious for isolation of many clones
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at different times in two independent experimental groups. Therefore, we used a damageless cell sorter, PERFLOW Sort (Furukawa Electric, Tokyo, Japan), for the single-cell cloning in this study. The timing of cloning was determined based on the report by Kim et al. (2014) . As expression of Cas9 protein can be detected until 24 hr post-transfection, at least 24 hr of incubation should be required before cloning. Therefore, we decided to carry out the cloning at four different time points (24, 48, 72 hr and 1 week post-transfection; Figure 2b ).
| Unexpected heterogeneity of clonal cells with long-term incubation before singlecell cloning
After the introduction of Cas9 RNPs using the Lipofectamine CRISPRMAX Cas9 Transfection Reagent, the cells were cultured for the required periods. Single-cell cloning was then carried out with a cell sorter. The viable cell populations were selected as indicated in Figure S1 . Single cells were isolated in 96-well plates and incubated for approximately 3 weeks. The clonal cells were subsequently collected and analyzed individually.
Initially, we carried out high-resolution microchip electrophoresis of the PCR products amplified from the clonal cells to detect single and multiple bands, indicating homogeneous and heterogeneous clones, respectively ( Figure 3) . Surprisingly, the results clearly showed that the frequency of heterogeneous clones was higher for long-term incubation after transfection (72 hr and 1 week) than for short-term incubation after transfection (24 and 48 hr). In particular, the majority of cells with 1 week of incubation showed heterogeneous band patterns. This tendency was observed in both the RNP_1 + 4 and RNP_2 + 4 + 5 groups.
We further analyzed the genotypes of all clones by Sanger sequencing. A few examples are shown in Figure 4 . Consistent with the microchip electrophoresis analyses, the clones presenting a single band did not show any mixed chromatograms, whereas the clones presenting multiple bands showed mixed chromatograms, beginning around the cleavage sites of the crRNAs.
Taken together, short-term (24 and 48 hr), mid-term (72 hr) and long-term (1 week) incubation resulted in heterogeneous clones with frequencies of 11.8%-18.5%, 27.5%-35.7% and 64.6%-72.2%, respectively ( Figure 5 ).
F I G U R E 1 Design and initial
validation of the crRNAs. (a) Initial design of the crRNAs used in this study. The target sequences of Cas9 RNPs are colored or underlined (red, crRNA #1; purple, crRNA #2; blue, crRNA #3; underline, crRNA #4; green, crRNA #5). Protospacer adjacent motif (PAM) sequences are shown in bold letters. (b) Potential off-target sites identified using a cosmid web tool (https:// crispr.bme.gatech.edu/). Red letters indicate mismatched bases. (c) Pseudo-gel image of the activity validation. The products of genomic cleavage detection assays were electrophoresed within a MultiNA system. The mutation rates (%NHEJ) were calculated as previously described (Hansen et al., 2012 
| Mutation analysis of Cas9
RNP-introduced cells with or without a medium change
Although the results of the clonal analyses were rather unexpected, we could suggest that a possible reason for the phenomenon was continuous uptake of Cas9 RNPs from the culture medium. We did not change the medium used for transfection during the post-transfection incubation, except when the cells were moved to a larger multiwell plate in the group with 1 week of incubation. Therefore, we carried out side-by-side comparisons of mutation rates between samples with and without a medium change on the day after transfection. We transfected Cas9
RNPs containing crRNA #2 and carried out a restriction fragment length polymorphism (RFLP) analysis (Figure 6a ). RFLP analysis is frequently used for quantification of mutation rates when the mutagenic efficiency is high (Nakagawa et al., 2014a (Nakagawa et al., , 2014b Suzuki et al., 2013) , because the linearity of quantification by genomic cleavage detection assays is relatively low in such cases. As expected, the mutation rate for each incubation time remained the same in the group with a medium change, where transfectable Cas9 RNPs has been removed on the day after transfection, while an elevated mutation rate was observed for long-term incubation in the group without a medium change, where transfectable Cas9 RNPs could be continuously incorporated until the collection of the cells (Figure 6b,c) . Therefore, we concluded that the Lipofectamine/RNP complex remained active in the culture medium during long-term incubation and may have a great influence on the mutation efficiency and heterogeneity.
| DISCUSSION
In this study, we initially designed experiments to determine the optimal timing for single-cell cloning after genome editing operations. We selected the Cas9 RNP system, which is considered a temporal genome editing tool that possesses mutational activity for only a limited period of time (until ~24 hr). In fact, electroporation-mediated introduction of Cas9 RNPs was previously reported to induce mutations quickly, and the introduced Cas9 proteins were degraded rapidly .
We observed minimum mutation and heterogeneity frequencies in the groups with 24-48 hr of incubation after transfection, while longer incubation (≥72 hr) resulted in higher mutation and heterogeneity frequencies under particular conditions. The major difference between the experiments carried out by Kim and colleagues and our own was the method of transfection: electroporation vs. lipofection. In the electroporation experiments, intact Cas9 RNPs were added, but were not transfectable by themselves. Therefore, residual Cas9 RNPs after electroporation could not be incorporated into the cells, even if the medium was not removed. However, in the lipofection experiments, Cas9 RNPs were complexed with cationic lipids which were transfectable by themselves. Therefore, it is suggested that longer culture without a medium change could result in the continuous uptake of RNPs, followed by accumulation of functional Cas9 RNP in each cell before single-cell cloning, and highly frequent emergence of heterogeneity during cell divisions after cloning. Recent study by Tu and colleagues, reporting that the shortening the half-life of Cas9 could reduce mosaic mutations in fertilized zygotes (Tu et al., 2017) , partly supports our findings.
Elucidating the mechanism underlying our observations involves several challenges and limitations. First, heterogeneity would also be observed with a single G2 cell with two copies of the target and/or insufficient sorting. It is difficult to omit such an unintended outcome from the results, or to include appropriate controls. Nevertheless, the experimental conditions were identical among the samples of 24, 48, 72 hr and 1 week; therefore, the conclusion of this study does not change even if such unintended heterogenous clones are included. Second, in the mutation analysis with or without a medium change, we had to use a single crRNA because it was difficult to quantify various types of deletions introduced with multiple crRNAs at the population level. Therefore, the effect of continuous Cas9 RNP uptake F I G U R E 6 Effect of a medium change at 21 hr after transfection on mutation efficiency. (a) Schematic illustration of the assay. Digested and undigested fragments were produced in wild-type and mutant alleles, respectively, by Bsp1286I treatment. Bold arrows indicate the positions of PCR primers. This figure was partly seen using snapgene viewer software. (b) Pseudo-gel image of a restriction fragment length polymorphism analysis. M, DNA ladder marker; U, untransfected control. (c) Increased mutation rates in samples without a medium change. Longer incubation with the Lipofectamine/RNP complex resulted in higher mutation efficiency. Mutation rates were calculated as follows: (uncut area)/(total area) × 100. Data are expressed as mean ± SEM (n = 3). All measurements were taken from distinct samples. p value represents two-tailed value for chi-squared test
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was slightly lower than in the single-cell cloning analysis. We nevertheless observed a significant difference when the media were unchanged. Third, regarding the dependency on crRNA, we did not include mock Cas9 RNP controls. However, mutation and heterogeneity patterns clearly differed between the RNP_1 + 4 and RNP_2 + 4 + 5 groups, suggesting that these mutations and heterogeneity were crRNA-dependent.
Importantly, we judged the existence and nonexistence of heterogeneity by the mixed and unmixed peaks of Sanger sequencing, respectively. Therefore, our examination of heterogeneity was not based on single nucleotide polymorphisms but rather on insertions and/or deletions. Recently, unexpected heterogeneity and mutations in CRISPR-treated mice have been reported (Schaefer et al., 2017) , but this has been interpreted with caution by other researchers because various single nucleotide variations were observed (Lareau et al., 2017) . In contrast, our results were unquestionably confirmed by the shifted peak-dependent, natural polymorphismindependent detection of heterogeneity. In contrast, the clones with low-frequency heterogeneity might be overlooked based on our analyses, because both direct sequencing and microchip electrophoresis are not highly sensitive. TOPO cloning or deep sequencing should be carried out for further highsensitivity detection of heterogeneity. Nevertheless, at least statistical significance was confirmed by our double-checked genotyping analyses.
Despite this, our postulation that the continuous uptake of Cas9 RNPs causes high-frequency cell heterogeneity remains just a hypothesis, because a number of factors have yet to be elucidated. For example, the abundance of Cas9 protein, crRNAs and tracrRNA, the half-life of functional Cas9 RNPs in the cells and media, the transfectability of the Lipofectamine-RNP complex and genomic mutation signatures at different times could all affect heterogeneity. The possibility that the transfection reagent itself may impose an unforeseen effect during incubation should also be considered. Such factors should be assessed in future studies to understand the detailed mechanisms. Additionally, although we observed similar phenomena using the two combinations of crRNAs at the HPRT1 locus, it is still unclear whether our finding is locus/cell type-specific. Further investigations are needed to clarify this point.
Collectively, our findings suggest that the system for transfection and the subsequent procedure should be carefully chosen in accordance with the intended use of Cas9 RNPs. When limited mutational activity is preferred, electroporation or lipofection with a medium change should be selected. When maximum mutational activity is desired, lipofection with a long incubation without a medium change may be suitable. However, we also have to consider the possibility of increased off-target mutations and large chromosomal rearrangements if a longer incubation is conducted.
| EXPERIMENTAL PROCEDURES
| Preparation of reagents
The Cas9 protein, tracrRNA and crRNAs were provided by FASMAC Co. Ltd. (Kanagawa, Japan). The sequences of the RNAs used in this study are listed in Table S1 .
| Cell culture, incubation of Cas9
RNPs and transfection HCT116 cells were maintained in DMEM supplemented with 10% fetal bovine serum (FBS). Mycoplasma test was carried out using e-Myco Mycoplasma PCR Detection Kit (iNtRON Biotechnology, Seongnam, Korea). All transfection experiments were carried out with the Lipofectamine CRISPRMAX Cas9 Transfection Reagent according to the manufacturer's instructions with some modifications. Briefly, Cas9 protein, crRNA(s) and tracrRNA with Lipofectamine Cas9 Plus Reagent were diluted in Opti-MEM I Medium (Thermo Fisher Scientific) (tube A). In separate tubes, Lipofectamine CRISPRMAX Reagent was also diluted in Opti-MEM I Medium (tube B). After 5-10 min of incubation at room temperature, the solutions in tubes A and B were mixed and transferred to a 96-well plate. After 10 min of incubation at room temperature, 2.5 × 10 5 HCT116 cells were gently added and incubated at 37°C in a CO 2 incubator. The amounts of Cas9 protein, crRNA and tracrRNA introduced for each experiment were as follows: genomic cleavage detection assay, 10 μg of Cas9, 830 ng of crRNA and 1,670 ng of tracrRNA; single-cell cloning and RFLP analysis, 5 μg of Cas9, 415 ng of crRNA and 835 ng of tracrRNA.
| Genomic cleavage detection assay
Cells were collected at 72 hr post-transfection and subjected to genomic cleavage detection assays using a GeneArt Genomic Cleavage Detection Kit (Thermo Fisher Scientific) according to the manufacturer's instructions as described previously (Sakuma, Nishikawa, Kume, Chayama, & Yamamoto, 2014) . The primers used for the PCR amplification were as follows: on-target, 5′-GGTGTGGAAGTTTAA TGACTAAGAGGTGTTTG-3′ (forward) and 5′-TGAAAT GAAAGCAAGTATGGTTTGCAGAG-3′ (reverse); OT1, 5′-AGGTGTCTGTGTGAAGTGTTCTTGTTCC-3′ (forward) and 5′-CAGGACCAGCTCCAGCAGTCATAG-3′ (reverse); OT2-1, 5′-TGGCCTGTCTGCCTCCCTTC-3′ (forward) and 5′-CCTCGGCATGGCTGAACTATTG-3′ (reverse); OT2-2, 5′-GAAAGTGGAATGTCGAGGTCTC AGG-3′ (forward) and 5′-ACATACATGGGTTAGATG GAGGTAAATGC-3′ (reverse); OT3, 5′-CCAGTCACA CCTGAATCAGAATGGAG-3′ (forward) and 5′-ACAG ACCCACTCTGGCAGTAGAAGTTC-3′ (reverse); OT4, | Genes to Cells
5′-TGGTCACCGTAGACCCAACACC-3′ (forward) and 5′-GCAAGCTTTGCATTATTTCACCAGTG-3′ (reverse); OT5, 5′-GGTGTAGCATGCAAACAGTAAGTATAAGA TGGAG-3′ (forward) and 5′-GCCCATGATATTCTACAA ATGTCAGTTAGGTC-3′ (reverse). The products were electrophoresed within a MultiNA™ (hereinafter referred to as "MultiNA") system (Shimadzu Corporation) using a DNA-500 kit (Shimadzu Corporation) according to the manufacturer's instructions. The results were analyzed using the software MultiNA ver. 1.11 (Shimadzu Corporation). The raw data of MultiNA quantification are shown in Dataset S1.
| Single-cell cloning with a cell sorter
Cells were collected at the required times after transfection (24, 48, 72 hr or 1 week), suspended in PBS and filtered with a Flowmi Tip Strainer (Bel-Art Products, Wayne, NJ, USA). Single cells were sorted using a PERFLOW Sort and collected in 96-well plates containing DMEM supplemented with 10% FBS.
| Genotyping with microchip electrophoresis and Sanger sequencing
Cells were collected at approximately 3 weeks postcloning and lysed with the Cell Lysis Buffer contained in the GeneArt Genomic Cleavage Detection Kit according to the manufacturer's instructions. After PCR amplification with the ontarget primers described in Section 4.3, the products were subjected to electrophoresis or Sanger sequencing. Microchip electrophoresis was carried out as described above. Sanger sequencing was carried out by FASMAC Co. Ltd. or processed in an ABI 3130xl Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) with a BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific).
| RFLP analysis
For RFLP analysis, cells were cultured with or without a medium change at 21 hr post-transfection and collected at the required times (24, 48, 72 hr or 1 week). Cell pellets were lysed with the cell lysis buffer contained in the GeneArt Genomic Cleavage Detection Kit according to the manufacturer's instructions. After PCR amplification with the on-target primers described in Section 4.3, the products were digested with Bsp1286I and electrophoresed within the MultiNA system as described above. The raw data of MultiNA quantification are shown in Dataset S2.
